Table 2.
Follow-up completion and overall improvement.
| Outcome | SdMwoA (n = 82) | MwoA (n = 77) | p-value |
|---|---|---|---|
| 6-month follow-up | |||
| Completed follow-up, n (%) | 52 (63.4%) | 48 (62.3%) | 0.888 |
| Any improvementa, n (%) | 38 (73.1%) | 31 (64.6%) | 0.359 |
| Any improvement, LTFUb = improvement, n (%) | 68 (82.9%) | 60 (77.9%) | 0.426 |
| Any improvement, LTFU = no improvement, n (%) | 38 (46.3%) | 31 (40.3%) | 0.439 |
| SdMwoA (n = 86) | MwoA (n = 80) | p-value | |
|---|---|---|---|
| 12-month follow-up | |||
| Completed follow-up, n (%) | 48 (55.8%) | 49 (61.3%) | 0.478 |
| Any improvement, n (%) | 41 (85.4%) | 38 (77.6%) | 0.319 |
| Any improvement, LTFU = improvement, n (%) | 79 (91.9%) | 69 (86.3%) | 0.245 |
| Any improvement, LTFU = no improvement, n (%) | 41 (47.7%) | 38 (47.5%) | 0.982 |
| SdMwoA (n = 97) | MwoA (n = 95) | p-value | |
|---|---|---|---|
| Last follow-up | |||
| Completed follow-up, n (%) | 67 (69.1%) | 66 (69.5%) | 0.952 |
| Median follow-up duration, months median (IQR) | 25 (18, 39) | 26 (16, 42) | 0.601 |
| Any improvement, n (%) | 57 (85.1%) | 54 (81.8%) | 0.613 |
| Any improvement, LTFU = improvement, n (%) | 87 (89.7%) | 83 (87.4%) | 0.613 |
| Any improvement, LTFU = no improvement, n (%) | 57 (58.8%) | 54 (56.8%) | 0.778 |
a
Any improvement: remission or improved.
b
LTFU: lost to follow-up.